T1	Pharmacological_substance 0 12	Erythromycin
N1000 	Reference T1 MeSH:D004917	Erythromycin
T2	Pharmacological_substance 24 34	ergotamine
N1001 	Reference T2 MeSH:D004878	ergotamine
T3	Disorder 122 130	ischemia
N1 	Reference T3 UMLS:C0022116	ischemia
T4	Disorder 171 190	ischemic neuropathy
N2 	Reference T4 UMLS:C0238309	ischemic neuropathy
T5	Disorder 192 201	Vasospasm
N3 	Reference T5 UMLS:C0085616	Vasospasm
T6	Pharmacological_substance 218 228	ergotamine
N1002 	Reference T6 MeSH:D004878	ergotamine
T7	Pharmacological_substance 320 332	erythromycin
N1003 	Reference T7 MeSH:D004917	erythromycin
T8	Pharmacological_substance 337 347	ergotamine
N1004 	Reference T8 MeSH:D004878	ergotamine
T9	Disorder 388 396	ischemia
N4 	Reference T9 UMLS:C0022116	ischemia
T10	Pharmacological_substance 421 434	Nitroprusside
N1005 	Reference T10 MeSH:D009599	Nitroprusside
T11	Disorder 552 581	Ischemic monomelic neuropathy
T12	Disorder 622 637	axonal necrosis
T13	Disorder 653 688	loss of distal extremity blood flow
T14	Pharmacological_substance 714 726	erythromycin
N1006 	Reference T14 MeSH:D004917	erythromycin
T15	Pharmacological_substance 731 741	ergotamine
N1007 	Reference T15 MeSH:D004878	ergotamine
T16	Pharmacological_substance 825 847	ergotamine derivatives
T20	Disorder 35 47	intoxication
N5 	Reference T20 UMLS:C0728899	intoxication
T17	Subject 402 419	36-year-old woman
T24	Combination 694 705	association
T25	Speculation_cue 742 745	may
T27	Speculation_cue 861 873	with caution
